NUP57 Antibody

What is NUP57 and what role does it play in the nuclear pore complex?

NUP57 (Nucleoporin 57) is a key component of the nuclear pore complex that forms a conserved subcomplex with Nsp1 and Nup49 (the Nsp1-Nup49-Nup57 subcomplex). This subcomplex is critical for the structure and function of nuclear pores. NUP57 contains phenylalanine-glycine (FG) repeat domains that contribute to the permeability barrier of the nuclear pore and facilitate selective transport across the nuclear envelope. Additionally, NUP57 plays important roles in nuclear pore complex assembly and maintenance. The protein's structural features include an alpha-beta domain that may be involved in specific co-translational interactions, setting the stage for proper complex formation .

Research has demonstrated that the NE recruitment of Nup57 and Nup49 are co-dependent, consistent with biochemical and structural analyses showing their interdependent nature within the NPC architecture .

What antibody types are available for NUP57 research and what species do they detect?

While specific NUP57 antibodies aren't detailed in the provided search results, nucleoporin research often employs both monoclonal and polyclonal antibodies. For nuclear pore complex research generally, the mAb414 antibody is one of the most widely used reagents - it recognizes FG-repeat-containing nucleoporins, including NUP358, NUP214, NUP153, and NUP62 . Though not specific to NUP57, this antibody provides a valuable tool for contextualizing NUP57 research within broader NPC studies.

When selecting antibodies for NUP57 research, it's important to verify cross-reactivity across species of interest. Related nucleoporin antibodies have demonstrated reactivity with human, mouse, rat, and other mammalian samples .

What are the standard applications for NUP57 antibodies in research?

NUP57 antibodies can be employed in several common experimental applications:

• Western Blotting (WB): For detecting and quantifying NUP57 protein levels in cell or tissue lysates, providing information about expression levels.

• Immunocytochemistry/Immunofluorescence (ICC/IF): For visualizing the localization of NUP57 within cells, particularly at the nuclear envelope.

• Co-immunoprecipitation (Co-IP): For studying protein-protein interactions between NUP57 and other nucleoporins or binding partners.

• Chromatin Immunoprecipitation (ChIP): For investigating potential roles of NUP57 in gene regulation.

For optimal results in immunofluorescence applications, cells are typically fixed with 4% paraformaldehyde in appropriate buffer (e.g., DPBS) for approximately 20 minutes and permeabilized with 0.1% Triton X-100 for 20 minutes at room temperature . Blocking is commonly performed using normal serum (e.g., 2% normal goat serum) in buffer containing BSA before antibody application.

How does NUP57 interact with other components of the nuclear pore complex?

NUP57 forms a critical subcomplex with Nsp1 and Nup49, which is essential for proper NPC structure and function. This Nsp1-Nup49-Nup57 subcomplex interacts with other NPC components, including Nic96, which serves as a linker to connect this subcomplex to the core scaffold of the NPC .

Experimental evidence demonstrates that:

• NUP57 engages in co-translational assembly with nascent Nic96, indicating a process where assembly begins even while proteins are being synthesized .

• The alpha-beta domain of NUP57 may be instrumental in facilitating specific co-translational interactions with other NPC components, particularly Nsp1 .

• NUP57 and Nup49 exhibit co-dependent recruitment to the nuclear envelope, as evidenced by mutational studies of Nic96 .

These interactions are crucial for building the complex architecture of the NPC and ensuring its various functions in nucleocytoplasmic transport.

How can NUP57 antibodies be used to study NPC assembly during interphase?

NUP57 antibodies can be valuable tools for studying interphase NPC assembly through several methodological approaches:

• Co-immunostaining: Researchers can perform co-immunostaining with antibodies against NUP57 and other nucleoporins (such as those recognized by mAb414) to identify potential NPC assembly intermediates. Studies have shown that nucleoporins like NUP93, NUP107, and POM121 form focal structures in pore-free islands of the nuclear envelope that may represent assembly intermediates .

• Live-cell imaging: By generating GFP-tagged NUP57 constructs, researchers can visualize the recruitment dynamics of NUP57 during NPC assembly in real-time.

• Cell cycle manipulation: Treatments with cell cycle inhibitors like aphidicolin (DNA polymerase inhibitor) or roscovitine (CDK inhibitor) can help dissect the relationship between cell cycle progression and NPC assembly .

The formation of NPC intermediates can be monitored by detecting foci that are positive for certain nucleoporins but not yet recognized by mAb414, suggesting these represent structures in the middle of NPC formation . When analyzing such intermediates, it's important to collect a large number of immunofluorescence images (approximately 4,000 co-immunostaining images in one published study) to enable robust statistical analysis .

What approaches can be used to study the functional significance of NUP57's FG domains?

The FG domains of nucleoporins like NUP57 are critical for establishing the permeability barrier and facilitating selective transport through nuclear pores. Several methodological approaches can be employed to study their functional significance:

• Domain deletion studies: Research has shown that FG domains of the Nsp1-Nup49-Nup57 subcomplex can be deleted without loss of viability, though these deletions may result in growth defects . These studies require careful genetic manipulation techniques.

• Plasmid-based expression systems: A methodological approach involves using chromosomal null alleles complemented by plasmid-based expression of ΔFG nups, wherein each plasmid encodes multiple FG Nups that are colocated in specific NPC substructures .

• Growth assays: Serial dilution of equal numbers of cells onto rich media and monitoring growth at different temperatures can reveal phenotypic consequences of FG domain deletions .

• Quantitative growth measurements: Liquid culture growth analysis can provide quantitative measurements of doubling times, which can reveal subtle growth defects that might not be apparent in plate-based assays .

Results from such studies have shown that while deletion of all FG domains from the Nsp1-Nup49-Nup57 subcomplex alone doesn't cause significant growth defects, combining these deletions with FG domain deletions from nucleoporins at the nuclear face results in severe growth defects (doubling time of 6.1 hours versus 2-3 hours for control strains) . This suggests functional redundancy and cooperation between different FG domains in the NPC.

How do mutations in the alpha-beta domain of NUP57 affect its interactions with other nucleoporins?

The alpha-beta domain of NUP57 appears to play a role in mediating specific co-translational interactions with other nucleoporins. Research methodologies to study these effects include:

These findings suggest that while the alpha-beta domain may influence the stoichiometry of interactions within the CTN subcomplex, its deletion does not catastrophically disrupt NPC function.

What methodologies are effective for studying co-translational assembly of NUP57?

Co-translational assembly represents a mechanism by which proteins begin to assemble into complexes while they are still being synthesized. For studying co-translational assembly involving NUP57, the following methodologies have proven effective:

• Selective Ribosome Profiling (SeRP): This technique compares ribosome-protected mRNA footprints from a total translatome to those that are affinity-purified using a specific bait protein that may engage with nascent chains. This approach can reveal the onset of co-translational interactions within a given open reading frame .

• Domain mapping experiments: By generating constructs with specific domains deleted or mutated, researchers can identify the regions essential for co-translational interactions. For example, experiments have shown that the IM-1 domain is sufficient to recruit Nsp1 and Nup57 to nascent Nic96 .

• Translation-specific inhibitors: Reagents such as cycloheximide can be used in experimental designs to specifically inhibit translation and study its effects on complex assembly .

These approaches have revealed that NUP57 participates in co-translational assembly processes, which may be important for ensuring the specificity and efficiency of nuclear pore complex assembly.

What controls and validation steps are essential when using NUP57 antibodies in immunofluorescence studies?

When using NUP57 antibodies for immunofluorescence studies, several critical controls and validation steps should be implemented:

• siRNA knockdown validation: All putative foci detected by antibodies should be confirmed by transfection with siRNA targeting the respective nucleoporins. Depletion of signal after knockdown confirms the specificity of the antibody .

• Co-localization with established NPC markers: Using well-characterized antibodies like mAb414 as co-staining controls helps validate the specificity of NUP57 staining patterns .

• Multiple fixation and permeabilization protocols: Testing different protocols (e.g., paraformaldehyde fixation followed by Triton X-100 permeabilization) can help optimize signal-to-noise ratio and ensure reliable detection .

• Antibody dilution series: Optimizing antibody concentration is critical - for example, related nuclear pore antibodies have been successfully used at dilutions around 1:200 .

• Biological controls: Include cells with known alterations in NUP57 expression or localization as positive or negative controls.

For quantitative image analysis of nuclear pore components, collecting large datasets (approximately 4,000 co-immunostaining images in one study) enables robust statistical analysis and helps distinguish true biological phenomena from technical artifacts .

What are the key considerations when designing mutational studies of NUP57?

When designing mutational studies of NUP57, researchers should consider several important factors:

• Mutation strategy selection: Choose approaches that (a) avoid indirect effects from epitope or loxP tagging during strain construction, (b) allow straightforward future mutational analysis of sequences encoding individual domains, and (c) enable functional analysis of the resulting mutants .

• Complementation systems: Consider using chromosomal null alleles complemented by plasmid-based expression systems, which allow for more controlled and flexible experimental manipulation .

• Domain-specific targeting: Different domains of NUP57 serve distinct functions - the FG domains contribute to the permeability barrier while structural domains like the alpha-beta domain may be involved in specific protein-protein interactions .

• Viability assessment: Nuclear pore proteins often have essential functions, so it's important to determine whether mutations affect cell viability. Serial dilution growth assays at different temperatures can reveal conditional growth defects .

• Quantitative growth measurements: Liquid culture growth analysis provides more quantitative assessment of growth defects, revealing doubling times that might not be apparent in plate-based assays .

Research has shown that deletion of all three FG domains in the Nsp1-Nup49-Nup57 complex is viable with no noted growth defects at various temperatures tested, suggesting functional redundancy among FG domains in the NPC .

How can high-resolution imaging techniques be optimized for studying NUP57 localization?

Advanced imaging of NUP57 requires careful optimization of several parameters:

• Sample preparation:

  • Fixation: 4% paraformaldehyde in appropriate buffer (e.g., DPBS) for approximately 20 minutes

  • Permeabilization: 0.1% Triton X-100 for 20 minutes at room temperature

  • Blocking: 2% normal serum in buffer containing BSA

• Antibody selection and validation:

  • Primary antibodies specifically validated for NUP57

  • Secondary antibodies with minimal cross-reactivity

  • Consideration of multiple labels for co-localization studies

• Imaging parameters:

  • Super-resolution techniques (e.g., STORM, SIM, STED) to resolve the 100-150 nm diameter nuclear pores

  • Z-stack acquisition to capture the full nuclear envelope

  • Optimal exposure settings to minimize photobleaching while maintaining signal-to-noise ratio

• Image analysis:

  • Collection of large datasets (approximately 4,000 co-immunostaining images in published studies)

  • Statistical image analysis frameworks for quantitative assessment

  • Specialized algorithms for detecting and characterizing nuclear pore distributions

These optimizations enable researchers to precisely localize NUP57 within the nuclear pore complex and study its dynamic behavior in different cellular contexts.

What approaches can effectively distinguish between different assembly states of NUP57-containing complexes?

Distinguishing between different assembly states of NUP57-containing complexes requires multiple complementary approaches:

• Biochemical fractionation: Separation of cell lysates based on size or density can isolate different complexes containing NUP57, from small subcomplexes to fully assembled NPCs.

• Co-immunoprecipitation with staged complex members: Pulling down with antibodies against proteins that enter the assembly pathway at different stages can help identify intermediate complexes.

• Immunofluorescence pattern analysis: Different assembly states may show distinct localization patterns:

  • Fully assembled NPCs typically show punctate staining at the nuclear envelope recognized by mAb414

  • Assembly intermediates may form focal structures in pore-free islands that are recognized by specific nucleoporin antibodies but not yet by mAb414

• Cell cycle manipulation: Treating cells with cell cycle inhibitors like aphidicolin (DNA polymerase inhibitor) or roscovitine (CDK inhibitor) can help isolate specific assembly stages .

• Quantitative image analysis: Statistical frameworks applied to large image datasets can distinguish between different assembly states based on co-localization patterns and intensity distributions .

Research has shown that nucleoporins can form focal structures in both pore-free islands and pore-rich regions, with the former potentially representing assembly intermediates . These focal structures can be depleted by siRNA targeting the respective nucleoporins, confirming their identity .

What are common pitfalls in NUP57 antibody-based experiments and how can they be avoided?

Several common challenges arise when working with NUP57 antibodies:

• Cross-reactivity issues:

  • Problem: NUP57 shares structural similarities with other nucleoporins, potentially leading to non-specific binding.

  • Solution: Validate antibody specificity through siRNA knockdown experiments, western blot analysis showing a single band of appropriate molecular weight, and comparison with multiple antibodies targeting different epitopes .

• Variable fixation effects:

  • Problem: Different fixation methods can affect epitope accessibility.

  • Solution: Test multiple fixation protocols (paraformaldehyde, methanol, glutaraldehyde) to determine optimal conditions for your specific antibody .

• Insufficient permeabilization:

  • Problem: Nuclear envelope proteins may be inaccessible due to membrane barriers.

  • Solution: Optimize permeabilization using Triton X-100 (typically 0.1% for 20 minutes) or other detergents .

• Background signal:

  • Problem: High background can obscure specific nuclear pore staining.

  • Solution: Use appropriate blocking (2% normal serum in buffer with 1% BSA) and include wash steps with 0.1% Tween 20 .

• Misinterpretation of focal structures:

  • Problem: Distinguishing between mature NPCs and assembly intermediates can be challenging.

  • Solution: Use co-staining with established markers like mAb414 and collect sufficient images for statistical analysis .

How should researchers interpret conflicting data between different NUP57 detection methods?

When faced with conflicting results between different detection methods for NUP57:

• Method-specific limitations assessment:

  • Western blotting primarily detects denatured proteins and may miss conformational epitopes

  • Immunofluorescence preserves spatial information but may be affected by accessibility issues

  • Mass spectrometry provides unbiased detection but may miss low-abundance interactions

• Epitope consideration:

  • Different antibodies targeting different regions of NUP57 may give varying results depending on protein conformation or interaction status

  • Consider whether the epitope might be masked in certain protein complexes

• Experimental conditions:

  • Differences may be attributed to experimental design, particularly the use of translation-specific inhibitors such as cycloheximide, which can affect assembly processes

  • Cell cycle stage can significantly impact NPC composition and assembly state

• Biological versus technical variability:

  • Determine whether discrepancies represent genuine biological phenomena or technical artifacts

  • Replicate experiments with larger sample sizes to distinguish between these possibilities

• Orthogonal validation:

  • Employ alternative, independent methods to corroborate findings

  • Consider genetic approaches (e.g., fluorescent protein tagging at the endogenous locus) to complement antibody-based detection

When interpreting conflicting data, it's essential to consider that NUP57 exists in different assembly states and complexes, and different methods may preferentially detect specific subpopulations.

What statistical approaches are recommended for analyzing NUP57 localization and distribution data?

Robust statistical analysis is essential for interpreting NUP57 localization and distribution data:

• Large dataset collection:

  • Gather approximately 4,000 co-immunostaining images to ensure sufficient statistical power

  • Include multiple biological replicates and technical replicates

• Colocalization analysis:

  • Pearson's correlation coefficient for measuring degree of overlap between NUP57 and other NPC markers

  • Mander's overlap coefficient for asymmetric distributions

  • Objects-based approaches that identify discrete structures before measuring overlap

• Spatial statistics:

  • Ripley's K-function or L-function to analyze the spatial distribution of NPCs

  • Nearest neighbor analysis to characterize clustering patterns

  • Statistical image analysis frameworks specifically developed for pore-free islands

• Comparative analysis across conditions:

  • ANOVA or appropriate non-parametric tests to compare distributions across experimental conditions

  • Bootstrapping approaches to estimate confidence intervals for measurements

  • Multiple testing correction (e.g., Bonferroni or false discovery rate) when performing numerous comparisons

• Temporal analysis:

  • Time series analysis for live-cell imaging data

  • Hidden Markov models to identify transition states in assembly processes

What emerging technologies show promise for advancing NUP57 research?

Several cutting-edge technologies hold potential for transformative advances in NUP57 research:

• Cryo-electron tomography: This technique can reveal the native 3D structure of nuclear pores in their cellular context at sub-nanometer resolution, allowing visualization of NUP57's position and interactions within the assembled NPC.

• Proximity labeling approaches: BioID or APEX2 fused to NUP57 can identify proximal proteins in living cells, revealing the protein neighborhood around NUP57 and potentially uncovering novel interaction partners.

• Live-cell single-molecule tracking: Super-resolution microscopy combined with particle tracking can follow individual NUP57 molecules during NPC assembly, providing insights into assembly kinetics and mechanisms.

• Selective ribosome profiling (SeRP): This technique has already been applied to study co-translational interactions of NUP57 and could be extended to investigate how these interactions are regulated under different cellular conditions .

• CRISPR-based genomic tagging: Endogenous tagging of NUP57 enables visualization and analysis of the protein under physiological expression levels and regulation.

• Integrative structural biology: Combining X-ray crystallography, NMR, crosslinking mass spectrometry, and computational modeling to build comprehensive structural models of NUP57-containing subcomplexes.

These technologies will enable researchers to address fundamental questions about NUP57's role in nuclear pore complex assembly, maintenance, and function with unprecedented resolution and accuracy.

What unresolved questions about NUP57 represent important research opportunities?

Several key questions about NUP57 remain unanswered and represent significant research opportunities:

• Assembly mechanism precision: How is the stoichiometry of the Nsp1-Nup49-Nup57 subcomplex precisely maintained during assembly? What molecular mechanisms ensure correct incorporation into the larger NPC structure?

• Regulatory dynamics: How is NUP57 assembly and function regulated during different cellular processes such as mitosis, differentiation, and stress responses?

• Disease implications: What roles might NUP57 disruption play in diseases associated with nuclear pore defects, such as certain cancers, neurodegenerative disorders, or premature aging syndromes?

• Evolutionary conservation: How have the structure and function of NUP57 evolved across different organisms, and what does this reveal about fundamental mechanisms of nuclear transport?

• Transport selectivity contribution: How do the FG domains of NUP57 specifically contribute to the selective permeability barrier of the nuclear pore, particularly in cooperation with other FG-containing nucleoporins?

• Gene expression regulation: Does NUP57 play roles beyond structural components of the NPC, potentially in gene regulation or chromatin organization?

Addressing these questions will require integrating multiple research approaches, from structural biology and biophysics to cell biology and genetics, and will significantly advance our understanding of nuclear pore complex biology.